TickerFacts.

Translational Development Acquisition Corp. (TDAC): Net Income

Annual figures by period end, from SEC filings.

$6.36M
Year ended 2025-12-31
$5.54M
Trailing 12 months to 2026-06-30
2023-12-31: -$485.6K2024-12-31: -$71.0K2025-12-31: $6.36M$6.36M
2023-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$6.36Mn/m2026-03-30, From 2025-01-01
2024-12-31-$71.0Kn/m2026-03-30, From 2024-01-01
2023-12-31-$485.6Kn/a2025-03-31, From 2023-01-01

Net Income at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Translational Development Acquisition Corp. (TDAC)2025-12-31$6.36Mn/m
Newbury Street II Acquisition Corp (NTWO)2025-12-31$6.62Mn/a
Globa Terra Acquisition Corp (GTERA)2025-12-31$2.88Mn/a
Copley Acquisition Corp (COPL)2025-12-31$4.13Mn/a
1RT Acquisition Corp. (ONCH)2025-12-31$2.89Mn/a
Dynamix Corp (DYNC)2025-12-31-$13.22Mn/a
Twelve Seas Investment Co III/Cayman (TWLV)2025-12-31$37.0Kn/a
Oaktree Acquisition Corp. III Life Sciences (OACC)2025-12-31$7.29Mn/a
Thayer Ventures Acquisition Corp II (TVAI)2025-12-31$3.88Mn/a

Compare TDAC, NTWO, GTERA, COPL side by side · Screen every company in Blank Checks ↗